Janet M Duchek1, David A Balota2,1, Jewell B Thomas2, Abraham Z Snyder2,3, Patrick Rich4, Tammie L Benzinger3,5, Anne M Fagan2,5, David M Holtzman2,5, John C Morris2,5,6, Beau M Ances2,5,6,7. 1. Department of Psychology at Washington University in Saint Louis, Saint Louis, MO. 2. Department of Neurology at Washington University in Saint Louis, Saint Louis, MO. 3. Department of Radiology at Washington University in Saint Louis, Saint Louis, MO. 4. Department of Psychology at Kent State University, Kent, OH. 5. The Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University in Saint Louis, Saint Louis, MO. 6. The Hope Center at Washington University in Saint Louis, Saint Louis, MO. 7. Department of Bioengineering at Washington University in Saint Louis, Saint Louis, MOA.
Abstract
OBJECTIVE: Early biomarkers of Alzheimer's disease (AD) are needed for developing therapeutic interventions. Measures of attentional control in Stroop-type tasks discriminate healthy aging from early stage AD and predict future development of AD in cognitively normal individuals. Disruption in resting state functional connectivity MRI (rs-fcMRI) has been reported in AD and in healthy controls at risk for AD. We explored the relationship among Stroop performance, rs-fcMRI, and CSF Aβ₄₂ levels in cognitively normal older adults. METHOD: A computerized Stroop task (along with standard neuropsychological measures), rs-fcMRI, and CSF were obtained in 237 cognitively normal older adults. We compared the relationship between Stroop performance, including measures from reaction distributional analyses, and composite scores from four resting state networks (RSNs; default mode [DMN], salience [SAL], dorsal attention [DAN], and sensory-motor [SMN]), and the modulatory influence of CSF Aβ₄₂ levels. RESULTS: A larger Stroop effect in errors was associated with reduced rs-fcMRI within the DMN and SAL. Reaction time (RT) distributional analyses indicated the slow tail of the RT distribution was related to reduced rs-fcMRI functional connectivity within the SAL. Standard psychometric measures were not related to RSN composite scores. A relationship between Stroop performance and DMN (but not SAL) functional connectivity was stronger in CSF Aβ₄₂-positive individuals. CONCLUSIONS: A link exists between RSN composite scores and specific attentional performance measures. Both measures may be sensitive biomarkers for AD.
OBJECTIVE: Early biomarkers of Alzheimer's disease (AD) are needed for developing therapeutic interventions. Measures of attentional control in Stroop-type tasks discriminate healthy aging from early stage AD and predict future development of AD in cognitively normal individuals. Disruption in resting state functional connectivity MRI (rs-fcMRI) has been reported in AD and in healthy controls at risk for AD. We explored the relationship among Stroop performance, rs-fcMRI, and CSF Aβ₄₂ levels in cognitively normal older adults. METHOD: A computerized Stroop task (along with standard neuropsychological measures), rs-fcMRI, and CSF were obtained in 237 cognitively normal older adults. We compared the relationship between Stroop performance, including measures from reaction distributional analyses, and composite scores from four resting state networks (RSNs; default mode [DMN], salience [SAL], dorsal attention [DAN], and sensory-motor [SMN]), and the modulatory influence of CSF Aβ₄₂ levels. RESULTS: A larger Stroop effect in errors was associated with reduced rs-fcMRI within the DMN and SAL. Reaction time (RT) distributional analyses indicated the slow tail of the RT distribution was related to reduced rs-fcMRI functional connectivity within the SAL. Standard psychometric measures were not related to RSN composite scores. A relationship between Stroop performance and DMN (but not SAL) functional connectivity was stronger in CSF Aβ₄₂-positive individuals. CONCLUSIONS: A link exists between RSN composite scores and specific attentional performance measures. Both measures may be sensitive biomarkers for AD.
Authors: Yvette I Sheline; John C Morris; Abraham Z Snyder; Joseph L Price; Zhizi Yan; Gina D'Angelo; Collin Liu; Sachin Dixit; Tammie Benzinger; Anne Fagan; Alison Goate; Mark A Mintun Journal: J Neurosci Date: 2010-12-15 Impact factor: 6.167
Authors: Mathew R Brier; Jewell B Thomas; Abraham Z Snyder; Tammie L Benzinger; Dongyang Zhang; Marcus E Raichle; David M Holtzman; John C Morris; Beau M Ances Journal: J Neurosci Date: 2012-06-27 Impact factor: 6.167
Authors: Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson Journal: Neuron Date: 2009-07-30 Impact factor: 17.173
Authors: Julie Loebach Wetherell; Hayley S Ripperger; Michelle Voegtle; Beau M Ances; David Balota; Emily S Bower; Colin Depp; Lisa Eyler; Erin R Foster; Denise Head; Tamara Hershey; Steven Hickman; Noralinda Kamantigue; Samuel Klein; J Philip Miller; Michael D Yingling; Jeanne Nichols; Ginger E Nicol; Bruce W Patterson; Thomas L Rodebaugh; Joshua S Shimony; Abraham Snyder; Mary Stephens; Susan Tate; Mary L Uhrich; David Wing; Gregory F Wu; Eric J Lenze Journal: Clin Trials Date: 2020-06-27 Impact factor: 2.486
Authors: Andrew J Aschenbrenner; David A Balota; Anne M Fagan; Janet M Duchek; Tammie L S Benzinger; John C Morris Journal: J Int Neuropsychol Soc Date: 2015-09 Impact factor: 2.892
Authors: Karin L Meeker; Beau M Ances; Brian A Gordon; Cort W Rudolph; Patrick Luckett; David A Balota; John C Morris; Anne M Fagan; Tammie L Benzinger; Jill D Waring Journal: Neurobiol Aging Date: 2020-11-02 Impact factor: 4.673
Authors: Dean Ho; Stephen R Quake; Edward R B McCabe; Wee Joo Chng; Edward K Chow; Xianting Ding; Bruce D Gelb; Geoffrey S Ginsburg; Jason Hassenstab; Chih-Ming Ho; William C Mobley; Garry P Nolan; Steven T Rosen; Patrick Tan; Yun Yen; Ali Zarrinpar Journal: Trends Biotechnol Date: 2020-01-21 Impact factor: 19.536
Authors: Andrew J Aschenbrenner; David A Balota; Chi-Shing Tse; Anne M Fagan; David M Holtzman; Tammie L S Benzinger; John C Morris Journal: Neuropsychology Date: 2014-09-15 Impact factor: 3.295
Authors: Michael P Catalino; Shun Yao; Deborah L Green; Edward R Laws; Alexandra J Golby; Yanmei Tie Journal: Neurosurg Focus Date: 2020-02-01 Impact factor: 4.047
Authors: G Andrew James; Tonisha E Kearney-Ramos; Jonathan A Young; Clinton D Kilts; Jennifer L Gess; Jennifer S Fausett Journal: Brain Cogn Date: 2016-04-20 Impact factor: 2.310
Authors: Peter R Millar; Beau M Ances; Brian A Gordon; Tammie L S Benzinger; John C Morris; David A Balota Journal: J Cogn Neurosci Date: 2020-11-02 Impact factor: 3.225